Ingredient-example - FHIR v5.0.0-draft-final

R5 Final QA

This page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example Ingredient/example (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Ingredient.

Generated Narrative: Ingredient

Resource Ingredient "example"

status: active

role: ActiveBase (ingredientRole#ActiveBase)

Manufacturers

-

Manufacturer

*

Organization/example

substance
Codes
- Concept
* EQUIXABAN (substance#EQUIXABAN)
strength
presentation: 50 mg (Details: UCUM code mg = 'mg')/1 tablet (Details: UCUM code {tablet} = '{tablet}')
concentration: 5 mg (Details: UCUM code mg = 'mg')/1 mg (Details: UCUM code mg = 'mg')
referenceStrength
Substances
- Concept
* EQUIXABAN-SULPHATE (substance#EQUIXABAN-SULPHATE)
strength: 5.03 mg (Details: UCUM code mg = 'mg')/1 mg (Details: UCUM code mg = 'mg')

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.